US 12152067
Human antibodies to ebola virus glycoprotein
granted A61KA61K2039/507A61K39/3955
Quick answer
US patent 12152067 (Human antibodies to ebola virus glycoprotein) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61K, A61K2039/507, A61K39/3955, A61P, A61P31/14